SeaStar Medical (ICU) Competitors $0.79 -0.01 (-1.37%) Closing price 08/7/2025 04:00 PM EasternExtended Trading$0.81 +0.02 (+2.53%) As of 04:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ICU vs. CLGN, FEMY, DRIO, PETV, RVP, IRIX, ALUR, NXGL, NRXS, and NXLShould you be buying SeaStar Medical stock or one of its competitors? The main competitors of SeaStar Medical include CollPlant Biotechnologies (CLGN), Femasys (FEMY), DarioHealth (DRIO), PetVivo (PETV), Retractable Technologies (RVP), IRIDEX (IRIX), Allurion Technologies (ALUR), NexGel (NXGL), NeurAxis (NRXS), and Nexalin Technology (NXL). These companies are all part of the "medical equipment" industry. SeaStar Medical vs. Its Competitors CollPlant Biotechnologies Femasys DarioHealth PetVivo Retractable Technologies IRIDEX Allurion Technologies NexGel NeurAxis Nexalin Technology CollPlant Biotechnologies (NASDAQ:CLGN) and SeaStar Medical (NASDAQ:ICU) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, institutional ownership, earnings, media sentiment and valuation. Which has stronger earnings and valuation, CLGN or ICU? CollPlant Biotechnologies has higher revenue and earnings than SeaStar Medical. CollPlant Biotechnologies is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCollPlant Biotechnologies$510K71.83-$16.61M-$1.22-2.36SeaStar Medical$428K20.68-$24.83M-$3.47-0.23 Which has more risk and volatility, CLGN or ICU? CollPlant Biotechnologies has a beta of 1.47, suggesting that its share price is 47% more volatile than the S&P 500. Comparatively, SeaStar Medical has a beta of -1.04, suggesting that its share price is 204% less volatile than the S&P 500. Do insiders & institutionals believe in CLGN or ICU? 21.7% of CollPlant Biotechnologies shares are owned by institutional investors. Comparatively, 1.7% of SeaStar Medical shares are owned by institutional investors. 9.6% of CollPlant Biotechnologies shares are owned by insiders. Comparatively, 1.3% of SeaStar Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Is CLGN or ICU more profitable? SeaStar Medical has a net margin of 0.00% compared to CollPlant Biotechnologies' net margin of -560.92%. SeaStar Medical's return on equity of 0.00% beat CollPlant Biotechnologies' return on equity.Company Net Margins Return on Equity Return on Assets CollPlant Biotechnologies-560.92% -87.33% -65.31% SeaStar Medical N/A N/A -313.28% Does the media favor CLGN or ICU? In the previous week, SeaStar Medical had 5 more articles in the media than CollPlant Biotechnologies. MarketBeat recorded 6 mentions for SeaStar Medical and 1 mentions for CollPlant Biotechnologies. SeaStar Medical's average media sentiment score of 0.39 beat CollPlant Biotechnologies' score of 0.00 indicating that SeaStar Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CollPlant Biotechnologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SeaStar Medical 0 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts prefer CLGN or ICU? CollPlant Biotechnologies currently has a consensus price target of $11.50, indicating a potential upside of 299.31%. Given CollPlant Biotechnologies' stronger consensus rating and higher possible upside, equities research analysts clearly believe CollPlant Biotechnologies is more favorable than SeaStar Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CollPlant Biotechnologies 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00SeaStar Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryCollPlant Biotechnologies beats SeaStar Medical on 11 of the 16 factors compared between the two stocks. Get SeaStar Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for ICU and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ICU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ICU vs. The Competition Export to ExcelMetricSeaStar MedicalMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.97M$7.12B$5.48B$9.57BDividend YieldN/A2.83%3.99%4.18%P/E Ratio-0.2362.8629.8725.14Price / Sales20.6826.87422.9397.17Price / CashN/A26.5935.9458.58Price / Book-2.3217.548.105.59Net Income-$24.83M$239.96M$3.26B$265.48M7 Day Performance20.57%1.08%0.64%1.22%1 Month Performance-2.47%-3.72%2.42%0.39%1 Year Performance-89.92%22.84%27.60%23.47% SeaStar Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ICUSeaStar Medical1.1707 of 5 stars$0.79-1.4%N/A-89.9%$8.97M$428K-0.232News CoverageUpcoming EarningsGap DownCLGNCollPlant Biotechnologies1.542 of 5 stars$2.25-1.7%$11.50+411.1%-36.8%$29.13M$510K-1.8470FEMYFemasys2.8051 of 5 stars$0.81-1.4%$8.67+972.2%-16.0%$26.66M$1.70M-0.8930Upcoming EarningsDRIODarioHealth1.4531 of 5 stars$0.55+0.0%$2.00+263.6%-43.4%$25.03M$27.04M-0.98200Upcoming EarningsPETVPetVivoN/A$0.80-1.0%N/A+55.6%$22.00M$1.05M-1.7820News CoverageUpcoming EarningsGap UpRVPRetractable Technologies2.8848 of 5 stars$0.73-1.7%N/A-26.8%$21.86M$33.75M-1.35240Positive NewsIRIXIRIDEX0.3452 of 5 stars$1.32+3.1%N/A-30.8%$21.49M$48.67M-3.07120ALURAllurion Technologies1.9917 of 5 stars$2.85+2.9%$22.83+701.2%-85.2%$20.62M$32.11M-0.23501Upcoming EarningsNXGLNexGel0.5328 of 5 stars$2.60+1.2%N/A-5.4%$19.67M$8.69M-5.7810News CoverageGap UpNRXSNeurAxis2.8626 of 5 stars$2.52+0.8%$7.00+177.8%-14.9%$18.18M$2.93M-1.3719Gap UpNXLNexalin Technology2.8666 of 5 stars$0.99+0.5%$5.00+403.3%-10.6%$16.99M$131.07K-1.203Earnings ReportUpcoming EarningsGap Up Related Companies and Tools Related Companies CLGN Alternatives FEMY Alternatives DRIO Alternatives PETV Alternatives RVP Alternatives IRIX Alternatives ALUR Alternatives NXGL Alternatives NRXS Alternatives NXL Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ICU) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SeaStar Medical Holding Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share SeaStar Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
